Evidence map›Paper›PMID 39482739›Full record

ArticleJournal of pharmaceutical health care and sciences2024

Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic.

Akihiko Futamura, Takenao Koseki, Junichi Iida, Akito Suzuki, Nobuyuki Muroi, Michiaki Myotoku, Hiroki Maki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi and 2 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Akihiko FutamuraDepartment of Pharmacy, Fujita Health University Nanakuri Memorial Hospital, 424-1, Oodori, Tsu, Mie, 514-1295, Japan. futamura@fujita-hu.ac.jp.ORCID http://orcid.org/0000-0002-4393-7552
Takenao KosekiDepartment of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, 1-98, Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Junichi IidaHospitalization Support Center, Saiseikai Yokohama-Shi Nanbu Hospital, 3-2-10, Konandai Konan-Ku, Yokohama, Kanagawa, 234-0054, Japan.
Akito SuzukiDepartment of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Kyushu University of Medical Science, 1714-1 Yoshinomachi, Nobeoka, Miyazaki, 882-8508, Japan.
Nobuyuki MuroiDepartment of Pharmacy, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-Ku, Kobe, 650-0047, Japan.
Michiaki MyotokuFaculty of Pharmacy, Osaka Ohtani University, 3-11-1, Nishikioritaki, Tondabayashi, Osaka, 584-8540, Japan.
Hiroki MakiDepartment of Pharmacy, Kofu City Regional Medical Center, 1-18-1 Marunouchi, Kofu, Yamanashi, 400-8585, Japan.
Kazuhisa MizutaniDepartment of Pharmacy, Toya Onsen Hospital, 54-41 Abutagun Toyakocho, Hokkaido, 049-5892, Japan.
Hikaru OginoTokai Pharmacy, Tokai Pharmacy in Front of Nakatsugawa Municipal Hospital, 1666-1152 Komanbacho, Nakatsugawa, Gifu, 508-0011, Japan.
Yasuki TaniguchiDepartment of Pharmacy, Inabe General Hospital, 771 Hokuseichouageki, Inabe, 511-0428, Japan.
Keiichiro HigashiDepartment of Pharmacy, Asanogawa General Hospital, 83 Kosakamachinaka, Kanazawa, Ishikawa, 920-8621, Japan.
Masanobu UsuiDepartment of Surgery & Palliative Medicine, Fujita Health University School of Medicine, Toyoake, 470-1192, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to clarify the effectiveness of nutrition support team (NST) facilities for preventing central line-associated bloodstream infection (CLABSI).

methodsWe retrospectively analyzed the incidence of CLABSI as well as the presence or absence of additional medical fees for NST activity between 2019 and 2021, including the period before and after the COVID-19 pandemic. Subsequently, we performed between-group comparisons of the CLABSI incidence. CLABSI rates were compared based on cumulative per 1000 catheter uses during the relevant period.

resultsAmong 47 facilities that were registered for participation, there were 34 and 13 facilities with and without additional medical fees for NST activity (NST and non-NST groups, respectively). The CLABSI incidence rate was significantly lower in the NST group 0.96 [0.28-1.73] than in the non-NST group 1.25 [075-6.10] (p < 0.05). Before the pandemic, the NST group had a lower CLABSI rate per 1000 catheter uses than the non-NST group 2019: 0.70 [0.12-1.26] vs 2.10 [0.62-5.97]. During the pandemic, the CLABSI incidence showed no significant between-group difference 2020: 0.99 [0.51-1.61] vs 1.01 [0.80-4.16]; 2021: 1.24 [0.44-2.35] vs 1.96 [1.23-5.31]; however, the CLABSI rates in the NST group remained low.

conclusionDuring the COVID-19 pandemic, the incidence of CLABSI was lower in the NST group than in the non-NST group, indicating the effectiveness of NST in preventing the occurrence of CLABSI.

Indexed as

Additional medical fee for the nutrition support team activityCentral line-associated bloodstream infectionCOVID-19 pandemicNutrition support teamPharmacy

Identifiers

PMID39482739
PMCPMC11529453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.